What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review

What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review

<h3>Purpose </h3><p dir="ltr">Polypharmacy presents an increasing therapeutic challenge for physicians managing patients with chronic kidney disease (CKD). However, there is a lack of consensus regarding the specific medication count threshold that defines polypharmacy in...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Azhar Al-Khulaifi (13222233) (author)
مؤلفون آخرون:	Malkan Khatib (13135890) (author), Elrazi Ali (14777284) (author), Mohamed Yousif Ali (17808290) (author), Mohammed Ibn-Mas'ud Danjuma (17808293) (author)
منشور في:	2023
الموضوعات:	Biomedical and clinical sciences Clinical sciences Pharmacology and pharmaceutical sciences Adverse medication reactions Chronic kidney disease Medication Medication interactions Polypharmacy
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

What is Polypharmacy in Patients with Chronic Kidney Disease? A Systematic Review
حسب: Azhar, Al-Khulaifi
منشور في: (2023)

Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease
حسب: Asmaa, Al-mansouri
منشور في: (2023)

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis
حسب: Lina Naseralallah (14146465)
منشور في: (2023)

What is polypharmacy in people living with HIV/AIDS? A systematic review
حسب: Mohammed Ibn-Mas’ud Danjuma (13192169)
منشور في: (2022)

Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients
حسب: Asmaa Al-mansouri (16931739)
منشور في: (2021)

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
حسب: Naila Rabbani (291722)
منشور في: (2022)

Classification and segmentation of kidney MRI images for chronic kidney disease detection
حسب: Md. Sakib Bin Islam (20494559)
منشور في: (2024)

The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
حسب: Eman Wehedy (13275305)
منشور في: (2022)

The influence of the prebiotic gum acacia on the intestinal microbiome composition in rats with experimental chronic kidney disease
حسب: Arun Prasath Lakshmanan (6807152)
منشور في: (2021)

Prevalence of iron overload in patients with chronic kidney disease on peritoneal dialysis: A scoping review
حسب: Abdulqadir J. Nashwan (11659453)
منشور في: (2024)

Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients
حسب: Mohamed O. Saad (11659429)
منشور في: (2020)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
حسب: Awni Alshurafa (15468195)
منشور في: (2022)

Implications of the medication regimen complexity index score on hospital readmissions in elderly patients with heart failure: a retrospective cohort study
حسب: Asmaa Abdelbary (16400059)
منشور في: (2023)

Mycobacterium abscessus urinary tract infection in an immunocompetent host: A case report and literature review
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2022)

The Superiority of T2*MRI Over Serum Ferritin in the Evaluation of Secondary Iron Overload in a Chronic Kidney Disease Patient: A Case Report
حسب: Abdulrahman Al-Mashdali (16388474)
منشور في: (2021)

Pediatric rhabdomyolysis: a systematic review and meta-analysis of etiologies, management, and outcomes
حسب: Hany A. Zaki (17337673)
منشور في: (2025)

Drug contraindications in comorbid diseases: a protein interactome perspective
حسب: Kalyani B. Karunakaran (12478431)
منشور في: (2024)

Cardiovascular Efficacy and Safety of Finerenone: A Meta‐Analysis of Randomized Controlled Trials
حسب: Mushood Ahmed (19231379)
منشور في: (2025)

Network-based identification and prioritization of key transcriptional factors of diabetic kidney disease
حسب: Ikhlak Ahmed (150200)
منشور في: (2023)

Functional Validation and Network-Based Prioritization of Key Transcriptional Factors of Diabetic Kidney Disease
حسب: Ikhlak Ahmed (6428939)
منشور في: (2023)

Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital
حسب: Rana M Al AdAwi (16515256)
منشور في: (2021)

Dosage, time, and polytherapy dependent effects of different levetiracetam regimens on cognitive function
حسب: Jon Davis Perkins (17885747)
منشور في: (2023)

The effects of Ramadan fasting on clinical and biochemical markers among hemodialysis patients: A prospective cohort study
حسب: Emad Khazneh (4901830)
منشور في: (2019)

Outcomes of snuffbox arteriovenous fistula as a first-line approach to dialysis access in patients with end-stage kidney disease
حسب: Mohamed H. Khalaf (22225009)
منشور في: (2025)

The diagnostic value of DMSA scan in differentiating functional pseudo-tumors from malignancies in scarred kidneys: case series and literature review
حسب: Enas Hussein Mohammed (17733714)
منشور في: (2023)

Protein glycation – biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine
حسب: Naila, Rabbani
منشور في: (2021)

An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools
حسب: Mohammed Ibn-Mas’ud Danjuma (13192169)
منشور في: (2020)

Optimizing Mean Arterial Pressure Targets for Septic Shock Patients With Chronic Hypertension: A Narrative Review
حسب: Mutaz I. Othman (21186827)
منشور في: (2025)

Retrospective identification of medication related adverse events in the emergency medical services through the analysis of a patient safety register
حسب: Ian Howard (2026753)
منشور في: (2022)

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience
حسب: Mohamad M. Alkadi (14778640)
منشور في: (2020)

Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience
حسب: Mohamad M. Alkadi (14778640)
منشور في: (2021)

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar
حسب: Fatma Ben Abid (14150799)
منشور في: (2022)

Chronic reduction of store operated Ca<sup>2+</sup> entry is viable therapeutically but is associated with cardiovascular complications
حسب: Fang Yu (156838)
منشور في: (2022)

The prevalence of cardiac and hepatic iron overload in patients with kidney failure: A protocol for systematic review and meta‐analysis
حسب: Abdulqadir J. Nashwan (11659453)
منشور في: (2022)

Clinical characteristics and outcomes of patients with TSH-secreting pituitary adenoma and Graves’ disease - a case report and systematic review
حسب: Adeel Ahmad Khan (14152953)
منشور في: (2024)

Spontaneous tumor lysis syndrome in a patient with accelerated phase chronic myeloid leukemia treated successfully with rasburicase
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2022)

Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
حسب: Joan B Soriano (6458528)
منشور في: (2020)

Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia
حسب: Haitham Elbardisi (14058048)
منشور في: (2021)

Severe SARS‐CoV‐2 infection presenting with acute kidney injury and diabetic ketoacidosis complicated by pancreatitis in a 53‐year man with hypertension
حسب: Elrazi Ali (14777284)
منشور في: (2023)

Terlipressin‐induced foot ischemia
حسب: Fateen Ata (12217764)
منشور في: (2020)

Cannot write session to /tmp/vufind_sessions/sess_orl28pekk4jtbejdmurcp58lm8